Tekla Life Sciences Investors HQL:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 10:11 AM EDT
14.57quote price arrow up+0.15 (+1.04%)
Volume
12,518
52 week range
13.86 - 22.70
Loading...
  • Open14.45
  • Day High14.68
  • Day Low14.43
  • Prev Close14.42
  • 52 Week High22.70
  • 52 Week High Date08/26/21
  • 52 Week Low13.86
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap366.29M
  • Shares Out25.14M
  • 10 Day Average Volume0.08M
  • Dividend1.40
  • Dividend Yield9.61%
  • Beta0.88
  • YTD % Change-23.76

KEY STATS

  • Open14.45
  • Day High14.68
  • Day Low14.43
  • Prev Close14.42
  • 52 Week High22.70
  • 52 Week High Date08/26/21
  • 52 Week Low13.86
  • 52 Week Low Date05/12/22
  • Market Cap366.29M
  • Shares Out25.14M
  • 10 Day Average Volume0.08M
  • Dividend1.40
  • Dividend Yield9.61%
  • Beta0.88
  • YTD % Change-23.76

RATIOS/PROFITABILITY

  • EPS (TTM)2.62
  • P/E (TTM)5.57
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.139M
  • ROE (TTM)12.82%
  • Revenue (TTM)2.29M
  • Gross Margin (TTM)-145.05%
  • Net Margin (TTM)2,822.50%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date05/26/2022
  • Div Amount0.35
  • Split Date-
  • Split Factor-

Latest On Tekla Life Sciences Investors

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Tekla Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund's investment objective is long-term capital appreciation through investment in United States and foreign companies in the life sciences industry, including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies, and agriculture and environmental...
Oleg Pohotsky J.D.
Independent Chairman of the Board of Trustees
Daniel Omstead Ph.D.
President, Trustee
Address
100 FEDERAL STREET, 19TH FLOOR
Boston, MA
02109-4884
United States